Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Mem. Inst. Oswaldo Cruz ; 111(5): 311-321, May 2016. tab, graf
Artigo em Inglês | LILACS | ID: lil-782049

RESUMO

The organophosphate temephos has been the main insecticide used against larvae of the dengue and yellow fever mosquito (Aedes aegypti) in Brazil since the mid-1980s. Reports of resistance date back to 1995; however, no systematic reports of widespread temephos resistance have occurred to date. As resistance investigation is paramount for strategic decision-making by health officials, our objective here was to investigate the spatial and temporal spread of temephos resistance in Ae. aegypti in Brazil for the last 12 years using discriminating temephos concentrations and the bioassay protocols of the World Health Organization. The mortality results obtained were subjected to spatial analysis for distance interpolation using semi-variance models to generate maps that depict the spread of temephos resistance in Brazil since 1999. The problem has been expanding. Since 2002-2003, approximately half the country has exhibited mosquito populations resistant to temephos. The frequency of temephos resistance and, likely, control failures, which start when the insecticide mortality level drops below 80%, has increased even further since 2004. Few parts of Brazil are able to achieve the target 80% efficacy threshold by 2010/2011, resulting in a significant risk of control failure by temephos in most of the country. The widespread resistance to temephos in Brazilian Ae. aegypti populations greatly compromise effective mosquito control efforts using this insecticide and indicates the urgent need to identify alternative insecticides aided by the preventive elimination of potential mosquito breeding sites.


Assuntos
Animais , Aedes/efeitos dos fármacos , Insetos Vetores/efeitos dos fármacos , Resistência a Inseticidas , Inseticidas/farmacologia , Temefós/farmacologia , Bioensaio , Brasil , Larva/efeitos dos fármacos , Análise Espaço-Temporal
2.
Mem. Inst. Oswaldo Cruz ; 103(6): 535-539, Sept. 2008. graf, tab
Artigo em Inglês | LILACS | ID: lil-495727

RESUMO

We analyzed dengue incidence in the period between October 2006-July 2007 of 146 cities around the country were Larval Index Rapid Assay (LIRA) surveillance was carried out in October 2006. Of these, we chosen 61 cities that had 500 or more cases reported during this period. We calculated the incidence coefficient, the force of infection (¼) and the basic reproduction number (R0) of dengue in those 61 cities and correlated those variables with the LIRA. We concluded that ¼ and R0 are more associated with the number of cases than LIRA. In addition, the average R0 for the 2006/2007 dengue season was almost as high as that calculated for the 2001/2002 season, the worst in Brazilian history.


Assuntos
Animais , Humanos , Aedes , Surtos de Doenças , Dengue/epidemiologia , Insetos Vetores , Brasil/epidemiologia , Incidência , Larva , Densidade Demográfica , Vigilância da População , Estações do Ano
3.
Rev. Soc. Bras. Med. Trop ; 30(1): 69-72, jan.-fev. 1997.
Artigo em Português | LILACS | ID: lil-191208

RESUMO

After to characterize the clinic and epidemiological picture of the onchocerciasis in Yanomâmi region, RR, Brazil, begun in 1993, the National Health Foundation (FNS) implemented a Control and Treatment Pilot Project in Tootobi and Balawaú. Here, it was studied skin biopsies from 426 inhabitants. In the nodules of 86.7 per cent from patients was encountered Onchocerca volvulus. The over-all prevalence in the examined population was 66.2 per cent . The treatment with ivermectin covered 80.1 per cent of total population. Adverse reactions, light and moderate, of the medicament were reported in 12.3 per cent of the patients. These results agreeing with the medical literature and suggesting the viability of to increase of the programme for all Yanomâmi area in the next phase.


Assuntos
Humanos , Antiprotozoários/uso terapêutico , Avaliação de Programas e Projetos de Saúde , Dermatopatias Parasitárias/prevenção & controle , Ivermectina/uso terapêutico , Oncocercose/prevenção & controle , Antiprotozoários/efeitos adversos , Ivermectina/efeitos adversos , Projetos Piloto , Prevalência , Saúde da População Rural
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA